You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Endocrinol., 23 June 2023

Sec. Endocrinology of Aging

Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1238584

Corrigendum: High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity

  • 1. Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China

  • 2. Department of Biomedical Engineering, Duke University Pratt School of Engineering, Durham, NC, United States

  • 3. Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, United States

  • 4. School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China

Article metrics

View details

1,4k

Views

635

Downloads

In the published article, there was an error in affiliation 1. Instead of “Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, China”, it should be “Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China”.

In the published article, there was also an error regarding the affiliation for Liyun Zhang. Instead of having affiliation 5 Department of Rheumatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences; Tongji Shanxi Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, China, they should have affiliation 1 Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Affiliation 5 has now been removed.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

FSH, menopause, rheumatoid arthritis, disease activity, sex hormones

Citation

Zhang X, Qiao P, Guo Q, Liang Z, Pan J, Wu F, Wang X and Zhang L (2023) Corrigendum: High follicle-stimulating hormone level associated with risk of rheumatoid arthritis and disease activity. Front. Endocrinol. 14:1238584. doi: 10.3389/fendo.2023.1238584

Received

12 June 2023

Accepted

14 June 2023

Published

23 June 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2023

Updates

Copyright

*Correspondence: Liyun Zhang,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics